Influence of access site selection on PCI-related adverse events in patients with STEMI: Meta-analysis of randomised controlled trials

Heart

Volumn 98, Issue 4, 2012, Pages 303-311

  Mamas, Mamas A ^a,b   Ratib, Karim ^c   Routledge, Helen ^d   Fath Ordoubadi, Farzin ^a   Neyses, Ludwig ^a,b   Louvard, Yves ^e   Fraser, Douglas G ^a   Nolan, Jim ^c  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^d WORCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^e INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; APPLICATION SITE REACTION; ARTICLE; BLEEDING; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMORAL ARTERY; GENERAL ASPECTS OF DISEASE; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; MAJOR ADVERSE CARDIAC EVENT; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RADIAL ARTERY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTEMATIC REVIEW; VASCULAR ACCESS;

ANGIOPLASTY, BALLOON, CORONARY; FEMORAL ARTERY; HEMORRHAGE; HUMANS; INCIDENCE; MYOCARDIAL INFARCTION; RADIAL ARTERY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 84856221000     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-300558     Document Type: Article

References (35)

1. Moscucci M, Fox KA, Cannon CP, et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003;24:1815-23. (Pubitemid 37280247)
2. Budaj A, Eikelboom JW, Mehta SR, et al; OASIS 5 Investigators. Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes. Eur Heart J 2009;30:655-61.
3. Rao SV, Eikelboom JA, Granger CB, et al. Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007;28:1193-204. (Pubitemid 47343833)
4. Rao SV, Ou FS, Wang TY, et al. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv 2008;1:379-86.
5. Manoukian SV, Feit F, Mehran R, et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial. J Am Coll Cardiol 2007;49:1362-8. (Pubitemid 46476844)
6. Yang X, Alexander KP, Chen AY, et al. The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 2005;46:1490-5. (Pubitemid 41446184)
7. Feit F, Voeltz MD, Attubato MJ, et al. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. Am J Cardiol 2007;100:1364-9. (Pubitemid 47576015)
8. Montalescot G, White HD, Gallo R, et al. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. N Engl J Med 2006;355:1006-17. (Pubitemid 44343544)
9. Cannon CP, Harrington RA, James S, et al; PLATelet inhibition and patient Outcomes Investigators. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Lancet 2010;375:283-93.
10. Mehran R, Lansky AJ, Witzenbichler B, et al HORIZONS-AMI Trial Investigators. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet 2009;374:1149-59.
11. Verheugt FW, Steinhubl SR, Hamon M, et al. Incidence, prognostic impact and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention. JACC Cardiovasc Interv 2011;4:191-7.
12. Chase A, Fretz E, Warburton W, et al. Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg). Heart 2008;94:1019-25. (Pubitemid 352039884)
13. Jolly SS, Amlani S, Hamon M, et al. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J 2009;157:132-40.
14. Pristipino C, Trani C, Nazzaro MS, et al; Prospective REgistry of Vascular Access in Interventions in Lazio Region Study Group. Major improvement of percutaneous cardiovascular procedure outcomes with radial artery catheterisation: results from the PREVAIL study. Heart 2009;95:476-82.
15. Abbott JD, Ahmed HN, Vlachos HA, et al. Comparison of outcome in patients with ST-elevation versus non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention (from the National Heart, Lung and Blood Institute Dynamic Registry). Am J Cardiol 2007;100:190-5. (Pubitemid 47041983)
16. Hamon M, Nolan J. Should radial artery access be the "gold standard" for PCI? Heart 2008;94:1530-2.
17. Patterson T, Foale RA. If the radial artery is the new standard of care in primary percutaneous coronary intervention, why is most intervention done by the femoral approach? Heart 2011;97:521-2.
18. Vorobcsuk A, Kónyi A, Aradi D, et al. Transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction Systematic overview and metaanalysis. Am Heart J 2009;158:814-21.
19. Jolly SS, Yusuf S, Cairns J, et al; for the RIVAL trial group. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet 2011;377:1409-20.
20. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700.
21. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in metaanalyses. BMJ 2003;327:557-60.
22. Saito S, Tanaka S, Hiroe Y, et al. Comparative study on transradial approach vs. transfemoral approach in primary stent implantation for patients with acute myocardial infarction: results of the test for myocardial infarction by prospective unicenter randomization for access sites (TEMPURA) trial. Catheter Cardiovasc Interv 2003;59:26-33. (Pubitemid 36528794)
23. Cantor W, Puley G, Natarajan M, et al. Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIIa inhibition in acute myocardial infarctiondthe RADIAL-AMI pilot randomized trial. Am Heart J 2005;150:543-9. (Pubitemid 41317627)
24. Brasselet C, Tassan S, Nazeyrollas P, et al. Randomised comparisonof femoral versus radial approach for percutaneous coronary intervention using abciximab in acute myocardial infarction: results of the FARMI trial. Heart 2007;93:1556-61. (Pubitemid 350205549)
25. Yan Z, Zhou Y, Zhao Y, et al. Safety and feasibility of transradial approach for primary percutaneous coronary intervention in elderly patients with acute myocardial infarction. Chin Med J (Engl) 2008;121:782-6.
26. Chodor P, Krupa H, Kurek T, et al. Radial versus femoral approach for percutaneous coronary interventions in patients with acute myocardial infarction. (RADIAMI) A prospective randomized, single center clinical trial. Cardiol J 2009;16:332-40.
27. Gan L, Li Q, Liu R, et al. Effectiveness and feasibility of transradial approaches for primary percutaneous coronary intervention in patients with acute myocardial infarction. J Nanjing Med Univ 2009;23:270-4.
28. Hou L, Wei D, Li W, et al. Comparative study on transradial versus transfemoral approach for primary percutaneous coronary intervention in Chinese patients with acute myocardial infarction. Saudi Med J 2010;31:158-62.
29. Chodor P, Kurek T, Kowalczuk A, et al. Radial vs femoral approach with StarClose clip placement for primary percutaneous coronary intervention in patients with ST - elevation myocardial infarction. RADIAMI II: a prospective, randomised, single centre trial. Kardiol Pol 2011;69:763-71.
30. Vuurmans T, Byrne J, Fretz E, et al. Chronic kidney injury in patients after cardiac catheterisation or percutaneous coronary intervention: a comparison of radial and femoral approaches (from the British Columbia Cardiac and Renal Registries). Heart 2010;96:1538-42.
31. Hetherington SL, Adam Z, Morley R, et al. Primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: changing patterns of vascular access, radial versus femoral artery. Heart 2009;95:1612-18.
32. Arzamendi D, Ly HQ, Tanguay JF, et al. Effect on bleeding, time to revascularization and one-year clinical outcomes of the radial approach during primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Am J Cardiol 2010;106:148-54.
33. Yusuf S, Mehta SR, Chrolavicius S, et al. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 2006;354:1464-76.
34. Rao SV, O'Grady K, Pieper KS, et al. A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol 2006;47:809-16.
35. Amoroso G, Kiemeneij F. Transradial access for primary percutaneous coronary intervention: the next standard of care? Heart 2010;96:1341-4.